Natixis Advisors LLC Has $8.48 Million Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Natixis Advisors LLC trimmed its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 13.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 100,577 shares of the medical device company's stock after selling 16,232 shares during the quarter. Natixis Advisors LLC owned 0.05% of Cooper Companies worth $8,484,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently added to or reduced their stakes in the company. City Holding Co. acquired a new position in shares of Cooper Companies in the 1st quarter worth approximately $34,000. Covestor Ltd boosted its holdings in shares of Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after acquiring an additional 120 shares in the last quarter. Larson Financial Group LLC boosted its holdings in shares of Cooper Companies by 1,071.0% in the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after acquiring an additional 664 shares in the last quarter. HM Payson & Co. boosted its holdings in shares of Cooper Companies by 147.4% in the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after acquiring an additional 532 shares in the last quarter. Finally, UMB Bank n.a. boosted its holdings in shares of Cooper Companies by 16.7% in the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock worth $76,000 after acquiring an additional 129 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on COO shares. Mizuho reduced their target price on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a report on Wednesday, July 16th. UBS Group raised Cooper Companies to a "buy" rating in a report on Tuesday, June 17th. Robert W. Baird dropped their price objective on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research report on Friday, May 30th. Wells Fargo & Company dropped their price objective on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a research report on Friday, May 30th. Finally, Loop Capital set a $100.00 price objective on shares of Cooper Companies in a research report on Tuesday, June 17th. Three equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Cooper Companies has an average rating of "Moderate Buy" and an average price target of $96.73.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $71.45 on Tuesday. The firm has a fifty day moving average of $72.18 and a two-hundred day moving average of $80.45. The stock has a market capitalization of $14.29 billion, a price-to-earnings ratio of 34.68, a PEG ratio of 1.73 and a beta of 1.00. The Cooper Companies, Inc. has a 52 week low of $65.00 and a 52 week high of $112.38. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.93 by $0.03. The company had revenue of $1 billion during the quarter, compared to analysts' expectations of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The business's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.85 EPS. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.